Penumbra (NYSE:PEN) announced today that it received FDA clearance for its Thunderbolt thrombectomy platform for stroke.
DermaSensor announced today that it received Class IIb CE mark approval for its skin cancer detection device.
Karl Storz announced today that it received FDA clearance for the digital, camera-based Rubina Lens exoscope for open surgery.
W.L. Gore & Associates announced today that it received CE mark approval for its Viabahn Fortegra venous stent system.
EBR Systems said today that a new Medicare National Coverage Determination (NCD) will evaluate its leadless endocardial pacing technology.
Medtronic (NYSE:MDT) announced today that it received FDA 510(k) clearance for its Nellcor pulse oximetry system with the Nell-EQ intelligent processor.
Medtronic (NYSE:MDT) today announced the receipt of CE mark approval for its Stealth AXiS surgical system for ENT procedures.
The new vaccine aims to produce an immune response that will protect against many pathogens—including some circulating among wild animals that might jump into humans in the future.
A Phase III clinical trial led by Neeraj Agarwal, MD, FASCO, senior director of clinical research at Huntsman Cancer Institute and professor of internal medicine at the University of Utah (the U), has found that a combination prostate cancer treatment could prevent the disease from progressing into a harder-to-treat form of cancer in select patients.
A new method for whole-genome sequencing of hantaviruses improves on today’s strategies for identifying outbreaks.